NBK Capital provides funding to Dem Pharmaceutical

Home
News

Sunday 08, January 2012 by Robin Amlôt

NBK Capital provides funding to Dem Pharmaceutical

NBK Capital has completed an investment in Dem Pharmaceutical, a niche pharmaceutical company specialising in biological drugs that treat life-threatening conditions.

This content is available to registered users only.
Please click here to register/login.

Features & Analyses

Islamic Finance Barclays upbeat about Qatari banking sector

In its latest review of Qatar’s sovereign and banking sector, entitled Better than expected, Barclays said banking liquidity… read more

Investments Global accountants stick to plans for leases on balance sheets
Investment Banking Obligations and responsibilities of investment managers under draft SCA…
SME Finance Family businesses at the forefront of Middle East’s growth
Consumer Banking India's IT sector in unwelcome spotlight after ATM heist
see all archive